Thyroid hormone testing in the 21st century

Ravinder Jit Singh, Parmpreet Kaur

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Thyroid dysfunction and treatment follow up require accurate measurement of thyroid hormones. Most thyroid disease is treated on an outpatient basis; thus, assays have to be rapid and cost effective for optimal patient care. There are no rapid or point-of-care thyroid tests yet available, which could replace centralized automated thyroid testing. With the high population of thyroid dysfunction, it is important for thyroid assays to be available widely and locally. Immunoassays are most commonly used due to their ease and availability, but are limited in their accuracy. MS assays are much more specific, but are laborious with a high machine cost. Many hospitals may not be able to afford the machines and lack technical expertise. Sensitivity, specificity and standardization issues still result in substantial differences between various tests currently used for this population. To address these issues, new performance standards are being established by the professional organizations and technological advancements are being undertaken by instrument manufacturers. Automation solution is provided by various manufacturers and offers a choice for the hospital labs to select a platform which helps in their workflow and other chemistry testing. This has also resulted in decentralization and easy access to the thyroid testing. Even with these advancements, it is understandably confusing for clinicians to choose an assay for various clinical scenarios (20). As it becomes more available and standardized, LC-MS will continue to demonstrate its superiority to immunoassay.

Original languageEnglish (US)
JournalClinical Biochemistry
DOIs
StateAccepted/In press - 2016

Fingerprint

Thyroid Hormones
Assays
Thyroid Gland
Testing
Immunoassay
Point-of-Care Systems
Standardization
Professional Competence
Costs
Costs and Cost Analysis
Automation
Workflow
Thyroid Diseases
Availability
Politics
Population
Patient Care
Outpatients
Sensitivity and Specificity

Keywords

  • Immunoassays
  • LC-MS/MS
  • Thyroid

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Thyroid hormone testing in the 21st century. / Singh, Ravinder Jit; Kaur, Parmpreet.

In: Clinical Biochemistry, 2016.

Research output: Contribution to journalArticle

@article{a2a8aa528ef54f2a8c5c7417578f00fb,
title = "Thyroid hormone testing in the 21st century",
abstract = "Thyroid dysfunction and treatment follow up require accurate measurement of thyroid hormones. Most thyroid disease is treated on an outpatient basis; thus, assays have to be rapid and cost effective for optimal patient care. There are no rapid or point-of-care thyroid tests yet available, which could replace centralized automated thyroid testing. With the high population of thyroid dysfunction, it is important for thyroid assays to be available widely and locally. Immunoassays are most commonly used due to their ease and availability, but are limited in their accuracy. MS assays are much more specific, but are laborious with a high machine cost. Many hospitals may not be able to afford the machines and lack technical expertise. Sensitivity, specificity and standardization issues still result in substantial differences between various tests currently used for this population. To address these issues, new performance standards are being established by the professional organizations and technological advancements are being undertaken by instrument manufacturers. Automation solution is provided by various manufacturers and offers a choice for the hospital labs to select a platform which helps in their workflow and other chemistry testing. This has also resulted in decentralization and easy access to the thyroid testing. Even with these advancements, it is understandably confusing for clinicians to choose an assay for various clinical scenarios (20). As it becomes more available and standardized, LC-MS will continue to demonstrate its superiority to immunoassay.",
keywords = "Immunoassays, LC-MS/MS, Thyroid",
author = "Singh, {Ravinder Jit} and Parmpreet Kaur",
year = "2016",
doi = "10.1016/j.clinbiochem.2016.06.007",
language = "English (US)",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Thyroid hormone testing in the 21st century

AU - Singh, Ravinder Jit

AU - Kaur, Parmpreet

PY - 2016

Y1 - 2016

N2 - Thyroid dysfunction and treatment follow up require accurate measurement of thyroid hormones. Most thyroid disease is treated on an outpatient basis; thus, assays have to be rapid and cost effective for optimal patient care. There are no rapid or point-of-care thyroid tests yet available, which could replace centralized automated thyroid testing. With the high population of thyroid dysfunction, it is important for thyroid assays to be available widely and locally. Immunoassays are most commonly used due to their ease and availability, but are limited in their accuracy. MS assays are much more specific, but are laborious with a high machine cost. Many hospitals may not be able to afford the machines and lack technical expertise. Sensitivity, specificity and standardization issues still result in substantial differences between various tests currently used for this population. To address these issues, new performance standards are being established by the professional organizations and technological advancements are being undertaken by instrument manufacturers. Automation solution is provided by various manufacturers and offers a choice for the hospital labs to select a platform which helps in their workflow and other chemistry testing. This has also resulted in decentralization and easy access to the thyroid testing. Even with these advancements, it is understandably confusing for clinicians to choose an assay for various clinical scenarios (20). As it becomes more available and standardized, LC-MS will continue to demonstrate its superiority to immunoassay.

AB - Thyroid dysfunction and treatment follow up require accurate measurement of thyroid hormones. Most thyroid disease is treated on an outpatient basis; thus, assays have to be rapid and cost effective for optimal patient care. There are no rapid or point-of-care thyroid tests yet available, which could replace centralized automated thyroid testing. With the high population of thyroid dysfunction, it is important for thyroid assays to be available widely and locally. Immunoassays are most commonly used due to their ease and availability, but are limited in their accuracy. MS assays are much more specific, but are laborious with a high machine cost. Many hospitals may not be able to afford the machines and lack technical expertise. Sensitivity, specificity and standardization issues still result in substantial differences between various tests currently used for this population. To address these issues, new performance standards are being established by the professional organizations and technological advancements are being undertaken by instrument manufacturers. Automation solution is provided by various manufacturers and offers a choice for the hospital labs to select a platform which helps in their workflow and other chemistry testing. This has also resulted in decentralization and easy access to the thyroid testing. Even with these advancements, it is understandably confusing for clinicians to choose an assay for various clinical scenarios (20). As it becomes more available and standardized, LC-MS will continue to demonstrate its superiority to immunoassay.

KW - Immunoassays

KW - LC-MS/MS

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=84977598365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977598365&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2016.06.007

DO - 10.1016/j.clinbiochem.2016.06.007

M3 - Article

C2 - 27329994

AN - SCOPUS:84977598365

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

ER -